Earningsreport

Q2/2023 6/30/2023 EPS 0.490 ZacksConsensus -0.340 ActVsEst 0.830 - Beat

CollPlant Biotechnologies Ltd. - Ordinary Shares  (CLGN) 
US:NASDAQ Investor Relations: collplant.com/investor-relation